This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Jump to section
Related Articles
Cited By...
- Optimization of [18F]-FDOPA Brain PET Acquisition Times for Assessment of Parkinsonism in the Clinical Setting
- Evaluation of Neurodegenerative Disorders with Amyloid-{beta}, Tau, and Dopaminergic PET Imaging: Interpretation Pitfalls
- Simple Ratio Analysis of 18F-Fluorodopa Uptake in Striatal Subregions Separates Patients with Early Parkinson Disease from Healthy Controls
- Relationship of Striatal Dopamine Synthesis Capacity to Age and Cognition
- Quantification of Striatal Dopamine Transporters with 123I-FP-CIT SPECT Is Influenced by the Selective Serotonin Reuptake Inhibitor Paroxetine: A Double-Blind, Placebo-Controlled, Crossover Study in Healthy Control Subjects
- Reproducibility of 99mTc-TRODAT-1 SPECT Measurement of Dopamine Transporters in Parkinson's Disease
- Crossover Study of 99mTc-TRODAT-1 SPECT and 18F-FDOPA PET in Parkinson's Disease Patients
- Dosimetry of the Dopamine Transporter Radioligand 18F-FPCIT in Human Subjects
- Comparative Analysis of Striatal FDOPA Uptake in Parkinson's Disease: Ratio Method Versus Graphical Approach
- Vulnerability of the nigrostriatal system as detected by transcranial ultrasound
- N-(3-Iodoprop-2E-enyl)-2beta -carbomethoxy-3beta -(3',4'-dichlorophenyl)nortropane (beta -CDIT), a Tropane Derivative: Pharmacological Characterization as a Specific Ligand for the Dopamine Transporter in the Rodent Brain